MIA-M Percutaneous Annuloplasty System
Mitral Regurgitation
Pre-clinicalActive
Key Facts
About Micro Interventional Devices
Micro Interventional Devices is a private, pre-revenue medical device company developing a disruptive platform for transcatheter cardiac repair. Its core technology is the proprietary PolyCor anchoring system, which enables percutaneous annuloplasty procedures for treating tricuspid and mitral regurgitation. The company's lead product, the MIA-T system for tricuspid valve repair, has FDA Breakthrough Device designation and is in clinical trials, while the mitral system, MIA-M, anticipates first-in-human use in 2024. MID aims to transform structural heart disease treatment by offering surgical efficacy with the safety of a catheter-based approach.
View full company profileTherapeutic Areas
Other Mitral Regurgitation Drugs
| Drug | Company | Phase |
|---|---|---|
| AMEND™ Annuloplasty Ring | Valcare Medical | Early Feasibility |
| AMEND™ Transseptal Delivery System | Valcare Medical | Early Feasibility |
| GeminiOne TEER System | Peijia Medical | Pre-market (NMPA under review) |